Vicky A. Johnson

Array ( [id] => 20517718 [patent_doc_number] => 20260041821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-12 [patent_title] => DRUG-RELEASING COATING [patent_app_type] => utility [patent_app_number] => 19/350447 [patent_app_country] => US [patent_app_date] => 2025-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19350447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20458229 [patent_doc_number] => 20260007649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-08 [patent_title] => METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS [patent_app_type] => utility [patent_app_number] => 19/326649 [patent_app_country] => US [patent_app_date] => 2025-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19326649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20692874 [patent_doc_number] => 20260124277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-07 [patent_title] => TREATMENT OF IMMUNOSUPPRESSED SUBJECTS [patent_app_type] => utility [patent_app_number] => 19/315259 [patent_app_country] => US [patent_app_date] => 2025-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16891 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19315259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20254851 [patent_doc_number] => 12427184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Treatment of immunosuppressed subjects [patent_app_type] => utility [patent_app_number] => 19/186092 [patent_app_country] => US [patent_app_date] => 2025-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 16899 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19186092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20083555 [patent_doc_number] => 20250213491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES [patent_app_type] => utility [patent_app_number] => 19/081631 [patent_app_country] => US [patent_app_date] => 2025-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19081631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830796 [patent_doc_number] => 20250082582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES [patent_app_type] => utility [patent_app_number] => 18/955058 [patent_app_country] => US [patent_app_date] => 2024-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18955058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19629683 [patent_doc_number] => 20240408132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => HYPOHALOUS ACIDS FOR TREATING INFLAMMATORY DISEASES AND INHIBITING GROWTH OF MALIGNANCIES [patent_app_type] => utility [patent_app_number] => 18/811505 [patent_app_country] => US [patent_app_date] => 2024-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18811505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19930359 [patent_doc_number] => 12303552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => Treatment of immunosuppressed subjects [patent_app_type] => utility [patent_app_number] => 18/808392 [patent_app_country] => US [patent_app_date] => 2024-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 16931 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19882982 [patent_doc_number] => 12268664 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-08 [patent_title] => Administration of benzodiazepine compositions [patent_app_type] => utility [patent_app_number] => 18/782666 [patent_app_country] => US [patent_app_date] => 2024-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25392 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18782666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19792234 [patent_doc_number] => 12233157 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-02-25 [patent_title] => Hydrogel formulations and methods and devices for administration of the same [patent_app_type] => utility [patent_app_number] => 18/783305 [patent_app_country] => US [patent_app_date] => 2024-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 9 [patent_no_of_words] => 22346 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19553988 [patent_doc_number] => 20240365780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => MICROBIAL INOCULANT COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/777004 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19743852 [patent_doc_number] => 20250032417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => LYOPHILIZED METOLAZONE FORMULATION FOR PARENTERAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/775374 [patent_app_country] => US [patent_app_date] => 2024-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18775374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19722663 [patent_doc_number] => 20250025414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => READY-DELIVERY ORAL DOSAGE FORM FOR LABORATORY ANIMALS [patent_app_type] => utility [patent_app_number] => 18/774109 [patent_app_country] => US [patent_app_date] => 2024-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19496368 [patent_doc_number] => 20240335386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => POWDER COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/749881 [patent_app_country] => US [patent_app_date] => 2024-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18749881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19707752 [patent_doc_number] => 20250017894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => Formulation for Nasal Delivery of Cannabinoids [patent_app_type] => utility [patent_app_number] => 18/745406 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20418605 [patent_doc_number] => 20250380690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-18 [patent_title] => ANTIMICROBIAL ARTICLES HAVING PEELABLE LINERS AND MANUFACTURING METHODS [patent_app_type] => utility [patent_app_number] => 18/743225 [patent_app_country] => US [patent_app_date] => 2024-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18743225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20418604 [patent_doc_number] => 20250380689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-18 [patent_title] => METHOD FOR MITIGATING MICROBIAL ACTIVITY USING ANTIMICROBIAL ARTICLES [patent_app_type] => utility [patent_app_number] => 18/743204 [patent_app_country] => US [patent_app_date] => 2024-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18743204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19984111 [patent_doc_number] => 20250122333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/674209 [patent_app_country] => US [patent_app_date] => 2024-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18674209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462314 [patent_doc_number] => 20240315983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => DRUG DELIVERY SYSTEMS CONTAINING OXIDIZED CHOLESTEROLS [patent_app_type] => utility [patent_app_number] => 18/672534 [patent_app_country] => US [patent_app_date] => 2024-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15262 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462307 [patent_doc_number] => 20240315976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES [patent_app_type] => utility [patent_app_number] => 18/672320 [patent_app_country] => US [patent_app_date] => 2024-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65273 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672320 [rel_patent_id] =>[rel_patent_doc_number] =>)